Followers | 145 |
Posts | 27721 |
Boards Moderated | 3 |
Alias Born | 02/07/2004 |
Wednesday, March 17, 2021 9:19:13 AM
https://finance.yahoo.com/news/plastomics-evogenes-ag-seed-division-120000363.html
The parties will test in soybean, Evogene's candidate genes for insect control utilizing Plastomics' novel chloroplast transformation technology
ST. LOUIS, Mo. and REHOVOT, Israel, March 17, 2021 /PRNewswire/ -- Plastomics, Inc., an agricultural biotech company, developing a step change in trait delivery technology, and Evogene Ltd.'s, (NASDAQ: EVGN) (TASE: EVGN), Ag-Seed division, focusing on discovery and development of seed traits, announced today a collaboration agreement targeting novel insect control traits for soybean.
As part of the collaboration, Plastomics, utilizing its disruptive new technology, will introduce Evogene's insect control genes demonstrating new modes of action (MoAs) into soybeans. These genes, which were discovered using Evogene's GeneRator AI engine, have demonstrated insecticidal activity in different assays to controlling insect colonies that are resistant and susceptible to current commercial insect solutions. a significant challenge to soybean growers.
The global market for biotech seeds is projected to reach a size of US$45 Billion by 2027, where biotech soybeans accounting for about 48% of the current market, is predicted to grow at an annual rate of 6.7% through 2027[1],2. New MoA insect control products have the potential to deliver significant value to soybean growers by addressing the increasing resistance of insects to current insect solutions, all of which are essentially based on the same MoAs introduced decades ago. The combination of the Plastomics' platform together with Evogene's new MoA insect control genes, has the future potential for controlling insect species in soybean and other row crops.
Plastomics is a development stage company with novel technology to introduce traits into plants in a manner that overcomes deficits of traditional biotech trait introduction. Instead of relying on nuclear transformation, which is the basis for all current biotech crops on the market, Plastomics utilizes novel chloroplast transformation technology. Taking advantage of the crop's solar engine – the chloroplast – aims to solve challenges inherent in traditional gene transfer to bring a new generation of trait benefits across the value chain, including consumers, growers and seed producers.
Jeffrey Staub, Ph.D., CTO at Plastomics, stated: "We look forward to working with Evogene to develop transformative solutions for insect control in soybeans. The combination of insect control traits with novel modes of action partnered with Plastomics' novel delivery system creates the potential for a significant and needed step change in providing growers with safe, sustainable and effective tools for insect control."
Basia Vinocur, Ph.D., Evogene's VP-R&D Ag-Seeds, stated: "We are very pleased to enter into this relationship with Plastomics, utilizing their technology to introduce our candidate genes for insect control into crops. There is a dire need for new MoA insect control traits, and we are looking forward to addressing it through our joint efforts."
About Plastomics, Inc.:
Plastomics is a plant biotechnology company making more effective and sustainable crops by delivering valuable traits to the chloroplast – the solar engine of the plant. Plastomics is committed to using its technology to produce the next generation of agricultural crops to feed a growing world. Plastomics is located in St. Louis, Missouri in the center of the 39 North Innovation District in the middle of America's Heartland. This location provides access to the unique benefits of the technical expertise and specialized capabilities (e.g. greenhouse, growth chamber, tissue culture and advanced microscopy) of the Donald Danforth Plant Science Center. For more information, please visit www.plastomics.com
About Evogene's Ag-Seed division:
The Ag-Seed division is focusing on the discovery and development of novel seed trait products for fulfilling the growing demands for food, feed and other industrial market needs. The Ag-Seed division utilizes Evogene's state-of–the-art proprietary computational predictive platform, the CPB and its GeneRator AI engine, harnessing the power of big data and artificial intelligence, for the discovery and development of improved seed trait products.
About Evogene Ltd.:
Evogene (NASDAQ: EVGN), (TASE: EVGN) is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its broadly applicable Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through the power of Big Data and Artificial Intelligence, has been designed to computationally discover and guide the development of life-science products based on microbes, small molecules and genetic elements. Utilizing the CPB platform, Evogene and its subsidiaries are now advancing product pipelines for human microbiome-based therapeutics through Biomica Ltd., medical cannabis through Canonic Ltd., ag-biologicals through Lavie Bio Ltd., ag-chemicals through AgPlenus Ltd., seed traits through the Ag-Seeds division, and ag-solutions for castor oil production through Casterra Ltd. For more information, please visit www.evogene.com.
Recent EVGN News
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 10/15/2024 10:52:26 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/30/2024 08:01:47 PM
- Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals • PR Newswire (US) • 09/30/2024 11:00:00 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/30/2024 04:15:19 AM
- Form F-1 - Registration statement for certain foreign private issuers • Edgar (US Regulatory) • 09/19/2024 08:15:06 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/17/2024 11:00:12 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/16/2024 08:01:22 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/26/2024 01:30:23 PM
- Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement • PR Newswire (US) • 08/23/2024 12:55:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/23/2024 12:50:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/22/2024 11:00:28 AM
- Evogene Reports Second Quarter 2024 Financial Results • PR Newswire (US) • 08/22/2024 11:00:00 AM
- Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price Rule • PR Newswire (US) • 08/12/2024 11:11:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/12/2024 11:01:49 AM
- Evogene Schedules Second Quarter 2024 Financial Results Release • PR Newswire (US) • 08/12/2024 11:00:00 AM
- Casterra Announces the Completion of a Successful Castor Seed Growing and Harvesting Season in Brazil • PR Newswire (US) • 07/31/2024 11:00:00 AM
- Evogene Announces Expected Implementation of 1-for-10 Reverse Share Split • PR Newswire (US) • 07/23/2024 12:48:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/23/2024 11:00:10 AM
- ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants • PR Newswire (US) • 07/17/2024 12:00:00 PM
- Lavie Bio Announces Commercial Expansion of Yalos™ to Winter Wheat • PR Newswire (US) • 07/02/2024 11:00:00 AM
- Casterra Announces an Additional Purchase Order to Supply Castor Seeds to a New African Country • PR Newswire (US) • 06/25/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/17/2024 08:10:30 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/06/2024 08:02:44 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/23/2024 03:00:08 PM
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering • SNWV • Oct 18, 2024 9:31 AM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM